rs17036993
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_001190274.2(FBXO11):c.376A>T(p.Thr126Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0042 in 1,613,956 control chromosomes in the GnomAD database, including 281 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001190274.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO11 | NM_001190274.2 | c.376A>T | p.Thr126Ser | missense_variant | 3/23 | ENST00000403359.8 | NP_001177203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO11 | ENST00000403359.8 | c.376A>T | p.Thr126Ser | missense_variant | 3/23 | 1 | NM_001190274.2 | ENSP00000384823 |
Frequencies
GnomAD3 genomes AF: 0.0225 AC: 3431AN: 152202Hom.: 143 Cov.: 32
GnomAD3 exomes AF: 0.00554 AC: 1389AN: 250696Hom.: 58 AF XY: 0.00400 AC XY: 542AN XY: 135606
GnomAD4 exome AF: 0.00229 AC: 3344AN: 1461636Hom.: 137 Cov.: 31 AF XY: 0.00189 AC XY: 1373AN XY: 727070
GnomAD4 genome AF: 0.0226 AC: 3440AN: 152320Hom.: 144 Cov.: 32 AF XY: 0.0218 AC XY: 1621AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
FBXO11-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 28, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at